For the dumb hydroxychloroquine cultists

Discussion in 'Politics' started by exGOPer, Jul 28, 2020.

  1. gwb-trading

    gwb-trading

    #331     Dec 9, 2020
  2. exGOPer

    exGOPer

    “The Oklahoma Attorney General’s Office has been tasked with attempting to return a $2 million stockpile of a malaria drug once touted by former President Donald Trump as a way to treat the coronavirus,” the Frontier reports.

    “In April, Gov. Kevin Stitt (R), who ordered the hydroxychloroquine purchase, defended it by saying that while it may not be a useful treatment for the coronavirus, the drug had multiple other uses and ‘that money will not have gone to waste in any respect.'”
     
    #332     Jan 26, 2021
  3. exGOPer

    exGOPer

    “The Oklahoma Attorney General’s Office has been tasked with attempting to return a $2 million stockpile of a malaria drug once touted by former President Donald Trump as a way to treat the coronavirus,” the Frontier reports.

    “In April, Gov. Kevin Stitt (R), who ordered the hydroxychloroquine purchase, defended it by saying that while it may not be a useful treatment for the coronavirus, the drug had multiple other uses and ‘that money will not have gone to waste in any respect.'”
     
    #333     Jan 26, 2021
  4. Bugenhagen

    Bugenhagen

    Now the lupus capitol of América?
     
    #334     Jan 26, 2021
  5. gwb-trading

    gwb-trading

    After completing six proper in-depth randomised controlled medical trials involving over 6,000 participants the WHO declares that hydroxychloroquine is absolutely useless to treating COVDI-19. "High certainty evidence showed that hydroxychloroquine had no meaningful effect on preventing deaths and hospital admissions, while moderate certainty evidence showed that the drug had no meaningful effect on reducing the number of laboratory-confirmed Covid-19 infections." This puts the nail in the coffin of this hydroxychloroquine nonsense.

    Hydroxychloroquine: Drug touted by Trump should not be used to treat Covid-19, WHO experts say
    Tablets former president once called ‘tremendous’ proven to be useless in fight against coronavirus
    https://www.independent.co.uk/news/health/trump-covid-drug-hydroxychloroquine-malaria-b1809789.html


    The anti-malaria drug hydroxychloroquine has been officially discounted by the World Health Organisation (WHO) as a possible means of protecting people from contracting Covid-19.

    Previously hailed by the former US president, Donald Trump, as a “miracle drug”, the anti-inflammatory was found to have “no meaningful effect” on preventing the spread of coronavirus – with the WHO’s Guideline Development Group (GDG) noting researchers should invest their time exploring more promising treatments.

    The GDG, a panel of international experts, wrote in the British Medical Journal that their strong recommendation is based on high certainty evidence from six randomised controlled trials involving over 6,000 participants.

    While three of the trials enrolled people who had a known exposure to someone with coronavirus, three others enrolled participants who were unaware if they had been in close proximity to an infected person.

    According to the panel, high certainty evidence showed that hydroxychloroquine had no meaningful effect on preventing deaths and hospital admissions, while moderate certainty evidence showed that the drug had no meaningful effect on reducing the number of laboratory-confirmed Covid-19 infections.

    It was also concluded, with moderate certainty, that the medicine probably increases the risk of adverse effects which would, ultimately, lead to its discontinuation.

    Advising that the drug was no longer a “research priority”, the panel said factors such as resources, feasibility, acceptability and fairness for countries meant they were unlikely to change or withdraw their recommendation that it be shelved.

    Previous studies have come to similar conclusions about hydroxychloroquine but this is the first time the WHO has given official guidance on its potential – and indeed the first time there has ever been a Covid-19 drugs guideline.

    Back in June 2020, the first randomised study to assess if hydroxychloroquine had preventive measures against the virus found it was was no more effective than a placebo, a vitamin in this case, in preventing the virus.

    “The take-home message for the general public is that if you’re exposed to someone with Covid-19, hydroxychloroquine is not an effective post-exposure, preventive therapy,” the lead author of the study, Dr David R Boulware, from the University of Minnesota, said at the time.

    Another study, published in The Lancet medical journal, studied 96,000 hospitalised coronavirus patients at hundreds of hospitals across six continents. It found patients who used hydroxycholorquine, or its variant chloroquine, had a significantly higher risk of death than those who did not take the drug.

    Mr Trump was heavily criticised last year for repeatedly promoting the “tremendous” drug’s use despite White House officials denying its efficacy.

    Dr Anthony Fauci, America’s leading infectious disease expert, publicly rejected claims that the drug was effective as a treatment for the coronavirus – and assistant health secretary Dr Brett Giroir, who was leading the administration’s Covid-19 testing response at the time, told NBC in August that “evidence just does not show” the drug is “effective right now”.

    Researchers in the US eventually conducted a trial about the cocktail of drugs Mr Trump touted as an “extremely successful” preventive remedy to catching Covid.

    It was found that by taking his recommended dosage of both hydroxychloroquine and the antibiotic azithromycin, a patient’s chance of death increased by 27 per cent.

    “There is already a great number of studies that have evaluated hydroxychloroquine alone or in combination and it seems unlikely at this stage that any efficacy will ever emerge,” wrote the study’s authors in the journal Clinical Microbiology and Infection. “Our results suggest that there is no need for further studies evaluating these molecules.”

    The new WHO guideline hopes to quash the spread of misinformation as more recommendations for other Covid preventive drugs are added when evidence becomes available.
     
    #335     Mar 2, 2021
  6. gwb-trading

    gwb-trading

    #336     May 11, 2021
  7. Cow poop usually cures all ills in India. Maybe they should at least try it.
     
    #337     May 11, 2021
  8. Since you traffic in bullshit, it only stands to reason that you would think so.
     
    #338     May 11, 2021
  9. Good response Freddy! You are getting good at your remarks! You get a tiny medal for that.
     
    #339     May 11, 2021
  10. jem

    jem

    As I saw a few doctors say on the news...
    HCL may work if provided early...

    Links to the studies are provide in the meta study..

    I have no desire to debate this... read studies and tell us why they are flawed.


    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534595/



    Timing of HCQ provision


    It was striking that 100% of the 11 studies which provided HCQ early in the disease on an outpatient basis showed positive results. In two of the studies [9,10], the benefit was only a trend. However, the effects were clinically important. In the study of Mitjà et al. [9], resolution of symptoms was decreased from 12 to 10 days; in that of Skipper et al. [10], the rate of hospitalization was decreased by 60%. It is likely that if the studies had higher power, statistical significance would have been reached. In the 32 other studies, HCQ was provided on an inpatient basis in patients with more advanced disease. The studies were divided into early, late and ICU administration. Early provision—within 48 hours of admission—showed 67% (6/9) of the studies to have positive efficacy. Later provision—after 48 hours' admission or in the ICU—found positive efficacy in 40% (2/5). Thus, from 100% for early outpatient, to 67% for early hospital to 40% for later hospital provision, there appears to be a relationship with time of initiation of treatment, with better results observed the earlier HCQ is provided.
     
    #340     May 17, 2021